Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

Documenti analoghi

• Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis
  di: P, Shahul Hameed, et al.
  Pubblicazione: (2014)
• Benzimidazoles: Novel Mycobacterial Gyrase Inhibitors from Scaffold Morphing
  di: Hameed P, Shahul, et al.
  Pubblicazione: (2014)
• Left-Hand Side Exploration of Novel Bacterial Topoisomerase Inhibitors to Improve Selectivity against hERG Binding
  di: Hameed P, Shahul, et al.
  Pubblicazione: (2015)
• In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis
  di: Solapure, Suresh, et al.
  Pubblicazione: (2013)
• UDP-N-Acetylmuramic Acid l-Alanine Ligase (MurC) Inhibition in a tolC Mutant Escherichia coli Strain Leads to Cell Death
  di: Humnabadkar, Vaishali, et al.
  Pubblicazione: (2014)